Regulatory Information
GOLDPLUS UNIVERSAL PTE LTD
GOLDPLUS UNIVERSAL PTE LTD
Therapeutic
Prescription Only
Formulation Information
TABLET, FILM COATED
**DOSAGE & METHOD OF ADMINISTRATION:** **Adults and children aged 12 years and older** The recommended dose is one tablet once daily. **Special risk groups** Studies in special risk groups (elderly, renally or hepatically impaired patients) indicate that it is not necessary to adjust the dose of fexofenadine hydrochloride in these patients.
ORAL
Medical Information
**INDICATIONS & USAGE:** Fexofenadine Hydrochloride Tablets USP is indicated in adults and children 12 years and older for followings: - Relief of symptoms associated with seasonal allergic rhinitis. - Relief of symptoms associated with chronic idiopathic urticaria.
**CONTRAINDICATION:** Hypersensitivity to the active substance or to any of the excipients listed.
R06AX26
fexofenadine
Manufacturer Information
GOLDPLUS UNIVERSAL PTE LTD
Ind-Swift Limited
Active Ingredients
Documents
Package Inserts
Fexofen PI.pdf
Approved: June 14, 2022